DEF 14A

Company

Aptose Biosciences Inc.

Filed

December 30, 2024

Period of Report

January 27, 2025

Accession Number

0001193125-24-286050

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →